Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Mometasone Furoate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 known ✓ | P04150 | 5/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 7/20 | 1.00 |
| ▸ | LMNA | P02545 | 5/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 4/20 | 1.00 |
| ▸ | PGR | P06401 | 4/20 | 1.00 |
| ▸ | AR | P10275 | 3/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 2/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 1.00 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 1.00 |
| ▸ | USP2 | O75604 | 4/20 | 0.64 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.64 |
| ▸ | CNR1 | P21554 | 2/20 | 0.64 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.64 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 3/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mometasone Furoate SCHEMBL4568 | 1.00 | CYP3A4 (1.00) | CYP3A4NR3C1LMNAABCB11PGR | |
| Mometasone Furoate SCHEMBL8430908 | 1.00 | CYP3A4 (1.00) | CYP3A4NR3C1LMNAABCB11PGR | |
| Mometasone Furoate SCHEMBL12996648 | 1.00 | CYP3A4 (1.00) | CYP3A4NR3C1LMNAABCB11PGR | |
| Mometasone Furoate SCHEMBL4896227 | 1.00 | CYP3A4 (1.00) | CYP3A4NR3C1LMNAABCB11PGR | |
| Mometasone Furoate SCHEMBL8826257 | 1.00 | CYP3A4 (1.00) | CYP3A4NR3C1LMNAABCB11PGR | |
| Mometasone Furoate SCHEMBL7436523 | 1.00 | CYP3A4 (1.00) | CYP3A4NR3C1LMNAABCB11PGR | |
| Mometasone Furoate SCHEMBL25382496 | 1.00 | CYP3A4 (1.00) | CYP3A4NR3C1LMNAABCB11PGR | |
| Mometasone Furoate SCHEMBL2594997 | 1.00 | CYP3A4 (1.00) | CYP3A4NR3C1LMNAABCB11PGR | |
| Mometasone Furoate SCHEMBL13026146 | 1.00 | CYP3A4 (1.00) | CYP3A4NR3C1LMNAABCB11PGR | |
| Mometasone Furoate SCHEMBL600107 | 1.00 | CYP3A4 (1.00) | CYP3A4NR3C1LMNAABCB11PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 26692 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137657-A1 | METHODS AND COMPOSITIONS FOR TREATING GLUCOCORTICOID EXCESS | SPARROW PHARMACEUTICALS INC (US) | 2026-05-21 | — | — | US | claimed |
| US-20260137656-A1 | METHODS AND COMPOSITIONS FOR TREATING GLUCOCORTICOID EXCESS | SPARROW PHARMACEUTICALS INC (US) | 2026-05-21 | — | — | US | claimed |
| WO-2026100654-A1 | NUCLEIC ACID INTRODUCTION AID, NUCLEIC ACID INTRODUCTION AGENT, AND NUCLEIC ACID INTRODUCTION METHOD | 株式会社インファーマシア | 2026-05-15 | — | — | WO | claimed |
| US-20260130899-A1 | METHOD OF TREATMENT FOR PREVENTION OF GLUCOCORTICOID TOXICITY AND/OR ENHANCEMENT OF MUSCLE REGENERATION VIA NEUTROPHIL ELASTASE INHIBITION | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2026-05-14 | — | — | US | claimed |
| US-20260125686-A1 | COMPOSITIONS AND METHODS FOR MODULATION OF CFTR | CYSTIC FIBROSIS FOUND (US) | 2026-05-07 | — | — | US | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| EP-4736841-A1 | A MUCOADHESIVE LAYER FOR BUCCAL ADMINISTRATION OF AN ACTIVE PHARMACEUTICAL INGREDIENT | IQ medical GmbH (DE) | 2026-05-06 | — | — | EP | claimed |
| EP-4735431-A2 | MK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME | GILEAD SCIENCES, INC. (US) | 2026-05-06 | — | — | EP | claimed |
| US-12616803-B2 | Apparatus for dispensing inhalant medicament | METOPI PHARMACEUTICALS, INC. (US) | 2026-05-05 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| CN-1133004-A | Method for regulating substances | ASTRA AB (SE) | 1996-10-09 | — | — | CN | claimed |
| WO-1996024359-A1 | NOVEL PHARMACEUTICAL FORMULATION | ASTRA AKTIEBOLAG (SE) | 1996-08-15 | — | — | WO | claimed |
| WO-1996024355-A1 | NOVEL PHARMACEUTICAL COMBINATION | ASTRA AKTIEBOLAG (SE) | 1996-08-15 | — | — | WO | claimed |
| EP-0721348-A1 | MONOGLYCERIDE/LACTATE ESTER PERMEATION ENHANCER | ALZA CORPORATION (US) | 1996-07-17 | — | — | EP | claimed |
| WO-1996019198-A1 | AEROSOL DRUG FORMULATIONS | ASTRA AKTIEBOLAG (SE) | 1996-06-27 | — | — | WO | claimed |
| EP-0292893-B2 | Steroid lotion | SCHERING CORP (US) | 1995-11-29 | — | — | EP | claimed |
| US-5407663-A | Swishing solution in mouth, expectorating | EISEN DRORE (US) | 1995-04-18 | — | — | US | claimed |
| WO-1995009006-A1 | MONOGLYCERIDE/LACTATE ESTER PERMEATION ENHANCER | ALZA CORPORATION (US) | 1995-04-06 | — | — | WO | claimed |
| EP-0548114-B1 | MOMETASONE FUROATE MONOHYDRATE, PROCESS FOR MAKING SAME AND PHARMACEUTICAL COMPOSITIONS | SCHERING CORP (US) | 1994-11-02 | — | — | EP | claimed |
| EP-0262681-B1 | ANTI-INFLAMMATORY CREAM COMPOSITION | SCHERING CORPORATION (US) | 1991-04-24 | — | — | EP | claimed |